HIV 2-LTR experiment design optimization.
Clinical trials are necessary in order to develop treatments for diseases; however, they can often be costly, time consuming, and demanding to the patients. This paper summarizes several common methods used for optimal design that can be used to address these issues. In addition, we introduce a nove...
Main Authors: | LaMont Cannon, Cesar A Vargas-Garcia, Aditya Jagarapu, Michael J Piovoso, Ryan Zurakowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6224063?pdf=render |
Similar Items
-
HIV UTR, LTR, and Epigenetic Immunity
by: Jielin Zhang, et al.
Published: (2022-05-01) -
Use of HIV-1 LTR Sequence Variants as Prognostic Indicators of HIV Dementia
by: Wigdahl Brian, et al.
Published: (2005-12-01) -
Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
by: Colin LaMont, et al.
Published: (2022-07-01) -
Benzodiazepines Drive Alteration of Chromatin at the Integrated HIV-1 LTR
by: Weam Elbezanti, et al.
Published: (2020-02-01) -
Uracil DNA glycosylase 2 negatively regulates HIV-1 LTR transcription
by: Tupin Audrey, et al.
Published: (2009-09-01)